Advertisement

Topics

Less can be more at the end of life

20:00 EDT 15 May 2018 | AAAS

(Queensland University of Technology) Advances in medicine mean health care professionals can prolong life, yet some treatments have a low chance of providing tangible benefits to some patients, can result in a 'bad death' and represent a multi-million dollar cost to the public purse. A QUT-led collaboration between health and law researchers has just received $500,000 funding from the NHMRC to examine the issue and improve end-of-life care.

Original Article: Less can be more at the end of life

NEXT ARTICLE

More From BioPortfolio on "Less can be more at the end of life"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...